Omnicell OMCL
NASDAQ OMCL
$34.31 +0.44 (+1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Omnicell (OMCL) Notes Payables (2021 - 2025)

Updated

Omnicell's Notes Payables came in at $174.8 million for Q2 2025, up 0.1% from the prior quarter.

Analysis

Omnicell (OMCL) Notes Payables (2021 - 2025) Analysis & Trends

At the end of FY2024, Omnicell's Notes Payables was $174.32 million.

  • Notes Payables carries a three-year compound annual growth rate of -29.1% (FY2021 to FY2024).
  • Going back by year, Notes Payables was $488.15 million in FY2021.
  • The five-year range for quarterly Notes Payables is $174.32 million (Q4 2024) to $572 million (Q3 2024).
  • Business Quant data shows OMCL's Notes Payables at $174.56 million (Q1 2025), $174.32 million (Q4 2024) and $572 million (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Omnicell 1.54 Bn 636.87 Mn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 174.80 Mn
Mar 31, 2025 174.56 Mn
Dec 31, 2024 174.32 Mn
Sep 30, 2024 572.00 Mn
Mar 31, 2022 564.27 Mn
Dec 31, 2021 488.15 Mn
API Access

Omnicell Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=OMCL&period=max&api_key=YOUR_API_KEY